Skip to main content
. Author manuscript; available in PMC: 2019 Oct 1.
Published in final edited form as: Kidney Int. 2018 Jul 21;94(4):716–727. doi: 10.1016/j.kint.2018.05.015

Table 1 |.

Serum biochemistries at baseline (CKD study)

Group n BUN (mg/dL) Serum Cr (mg/dL) Serum Ca (mg/dL) Serum P (mg/dL)
WT-CKD/NP 6 15 ± 1 0.16 ± 0.02 11.3 ± 0.3 8.9 ± 0.5
PiT-2 HET-CKD/NP 5 16 ± 1 0.18 ± 0.01 10.6 ± 0.2 8.3 ± 0.3
WT-CKD/HP 8 17 ± 1 0.17 ± 0.02 11.1 ± 0.3 8.9 ± 0.5
PiT-2 HET-CKD/HP 10 16 ± 1 0.16 ± 0.01 10.9 ± 0.3 8.6 ± 0.2

Data are expressed as mean ± SEM and compared by one-way ANOVA followed by Tukey-Kramer test. A P-value less than 0.05 was considered statistically significant. BUN, blood urea nitrogen; Ca, calcium; CKD, chronic kidney disease; Cr, creatinine; HP, high (1.5%) P; NP, normal (0.5%) P; P, phosphate; PiT-2 HET, PiT-2 heterozygous knockout; WT, wild-type.